Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CHKA | P35790 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.34 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22693855 | 0.78 | CA2 (0.34) | CA2CA12CA1CA9CHKA | |
| SCHEMBL17453114 | 0.78 | MLYCD (0.35) | CA2CA12CA1CA9 | |
| SCHEMBL17453117 | 0.76 | ALDH1A1 (0.35) | CA2CA12CA1CA9 | |
| SCHEMBL18942822 | 0.76 | ALDH1A1 (0.35) | CA2CA12CA1CA9 | |
| SCHEMBL19115977 | 0.74 | — | — | |
| SCHEMBL17453118 | 0.73 | — | — | |
| SCHEMBL17453112 | 0.73 | CA12 (0.38) | CA2CA12CA1CA9 | |
| SCHEMBL19114901 | 0.73 | CA12 (0.38) | CA2CA12CA1CA9 | |
| SCHEMBL18942823 | 0.73 | CYP1A2 (0.39) | — | |
| SCHEMBL19920498 | 0.73 | CA12 (0.38) | CA2CA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10344006-B2 | Amine-containing acyclic hydrofluoroethers and methods of using the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-07-09 | — | — | US | disclosed |
| US-20190040024-A1 | AMINE-CONTAINING ACYCLIC HYDROFLUOROETHERS AND METHODS OF USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10344006-B2 | Amine-containing acyclic hydrofluoroethers and methods of using the same | AFF1, AFF2, FANCF | CA2 1177/4885CA12 718/4885CA1 193/4885 |
| US-20190040024-A1 | AMINE-CONTAINING ACYCLIC HYDROFLUOROETHERS AND METHODS OF USING THE SAME | AFF1, AFF2, FANCF | CA2 1177/4885CA12 718/4885CA1 193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.